Skip Navigation


JAC Advance Access originally published online on April 21, 2007
Journal of Antimicrobial Chemotherapy 2007 59(6):1182-1184; doi:10.1093/jac/dkm099
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
59/6/1182    most recent
dkm099v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Docherty, J. J.
Right arrow Articles by Booth, T. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Docherty, J. J.
Right arrow Articles by Booth, T. D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Resveratrol inhibition of Propionibacterium acnes

John J. Docherty1,*, Heather A. McEwen1, Thomas J. Sweet1, Erin Bailey1 and Tristan D. Booth2

1 Department of Microbiology, Immunology and Biochemistry, Northeastern Ohio Universities College of Medicine, 4209 State Route 44, Rootstown, OH 44272, USA 2 Royalmount Pharma, Inc., 6111 Royalmount Avenue, Montreal, Quebec, Canada H4P 2T4

Received 29 January 2007; returned 6 March 2007; revised 9 March 2007; accepted 12 March 2007

* Corresponding author. Tel: +1-330-325-6133; Fax: +1-330-325-5914; E-mail: jjd{at}neoucom.edu

Objectives: To evaluate the effects of the anti-inflammatory hydroxystilbene, resveratrol, on Propionibacterium acnes growth.

Methods: Three different strains of P. acnes were tested against resveratrol at concentrations between 0 and 200 mg/L. Piceatannol was included as a second hydroxystilbene to compare with resveratrol, and erythromycin and benzoyl peroxide were used as positive controls.

Results: After 24 h of treatment with resveratrol, the average 50% inhibitory concentration (IC50) was 73 mg/L and the average 100% inhibitory concentration (IC100) was 187 mg/L for the three strains of P. acnes tested. The IC50 and IC100 of piceatannol were 123 and 234 mg/L, respectively. The highest concentration of resveratrol tested (200 mg/L) was bactericidal, whereas lower concentrations were bacteriostatic.

Conclusions: Resveratrol, an anti-inflammatory hydroxystilbene, is capable of inhibiting P. acnes growth.

Keywords: antimicrobial activity , drug development , human disease


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
C.-C. Lu, H.-C. Lai, S.-C. Hsieh, and J.-K. Chen
Resveratrol ameliorates Serratia marcescens-induced acute pneumonia in rats
J. Leukoc. Biol., April 1, 2008; 83(4): 1028 - 1037.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.